Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Dyskinesia Agents”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Ended earlyNCT03250117
What this trial is testing

Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Who this might be right for
Parkinson Disease
Titan Pharmaceuticals 6
Testing effectiveness (Phase 2)Study completedNCT01491932
What this trial is testing

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT05021978
What this trial is testing

A Clinical Trial of PRAX-944 in Participants With Essential Tremor

Who this might be right for
Essential Tremor
Praxis Precision Medicines 24
Not applicableActive Not RecruitingNCT05043103
What this trial is testing

Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

Who this might be right for
Advanced Parkinson Disease
Britannia Pharmaceuticals Ltd. 312
Testing effectiveness (Phase 2)Study completedNCT01491529
What this trial is testing

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT05021991
What this trial is testing

A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor

Who this might be right for
Essential Tremor
Praxis Precision Medicines 133
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82
Large-scale testing (Phase 3)Enrolling By InvitationNCT06087276
What this trial is testing

Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)

Who this might be right for
Essential Tremor
Praxis Precision Medicines 1,000
Testing effectiveness (Phase 2)Study completedNCT01385592
What this trial is testing

Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+1 more
Novartis Pharmaceuticals 78
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Large-scale testing (Phase 3)Study completedNCT00000179
What this trial is testing

Agitation in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA)